Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Rev. chil. infectol ; 26(6): 499-503, dic. 2009. ilus
Artigo em Espanhol | LILACS | ID: lil-536828

RESUMO

Los sistemas multidrogas bacterianos contribuyen al desarrollo del fenotipo de multi-resistencia presentado por cepas de Acinetobacter baumannü, patógeno intrahospi-talario, que durante los últimos años ha incrementado su importancia por la creciente resistencia a carbapenémicos. El fenotipo de multi-resistencia está otorgado por la combinación de varios mecanismos de resistencia entre los cuales se encuentran estos sistemas de bombas de expulsión. El sistema multidroga AdeABC se ha detectado en muchas de estas cepas multi-resistentes de A. baumannü y, se ha relacionado con resistencia a diversos grupos de antimicrobianos, incluidos tigeciclina y meropenem. La inhibición de dichos sistemas multidrogas permitiría aumentar la eficacia de la terapia antimicrobiana. La siguiente revisión se enfoca en las bombas de expulsión multidrogas presentes en A. baumannü, con particular énfasis en el sistema AdeABC.


Bacterial multi-drugs systems contribute to the development of multi-resistance patterns of Acinetobacter baumannii, a nosocomial pathogen of increasing importance due to its emerging resistance to carbapenems. The multi-resistance phenomena is generated by a combination of mechanisms, one of which the efflux pump system. Many of these multiresistant isolates of A. baumannii harbor genes for the AdeABC multi-drug efflux system, related with resistance to various groups of antibacterial agents, including tygecicline and meropenem. Inhibition of these systems would allow to increase the efficacy of this antimicrobial. This review focuses on the multi-drug efflux pump system oí A. baumanni with special emphasis in the AdeABC system.


Assuntos
Acinetobacter baumannii/metabolismo , Antibacterianos/farmacocinética , Proteínas de Bactérias/metabolismo , Farmacorresistência Bacteriana Múltipla/fisiologia , Proteínas de Membrana Transportadoras/metabolismo , Acinetobacter baumannii/efeitos dos fármacos , Antibacterianos/farmacologia
2.
Biol. Res ; 33(2): 125-131, 2000. tab, graf, ilus
Artigo em Inglês | LILACS | ID: lil-443670

RESUMO

Alzheimer's disease (AD) is characterized by the deposition of amyloid beta-peptide (A beta) and neuronal degeneration in brain regions involved in learning and memory. One of the leading etiologic hypotheses regarding AD is the involvement of free radical-mediated oxidative stress in neuronal degeneration. Recent evidence suggests that metals concentrated in amyloid deposits may contribute to the oxidative insults observed in AD-affected brains. We hypothesized that A beta peptide in the presence of copper enhances its neurotoxicity generating free radicals via copper reduction. In the present study, we have examined the effect of the aggregation state of amyloid-beta-peptide on copper reduction. In independent experiments we measured the copper-reducing ability of soluble and fibrillar A beta(1-40) forms by bathocuproine assays. As it was previously observed for the amyloid precursor protein (APP), the A beta peptide showed copper-reducing ability. The capacity of A beta to reduce copper was independent of the aggregation state. Finally, the A beta peptide derived from the human sequence has a greater effect than the A beta peptide derived from the rat sequence, suggesting that histidine 13 may play a role in copper reduction. In agreement with this possibility, the A beta peptide reduces less copper in the presence of exogenous histidine.


Assuntos
Humanos , Cobre/metabolismo , Doença de Alzheimer/metabolismo , Peptídeos beta-Amiloides/metabolismo , Doença de Alzheimer/etiologia , Estresse Oxidativo/fisiologia , Oxirredução , Peroxidação de Lipídeos/fisiologia , Precursor de Proteína beta-Amiloide/metabolismo
3.
Acta gastroenterol. latinoam ; 23(3): 143-7, July-Sept. 1993. tab
Artigo em Espanhol | LILACS | ID: lil-126693

RESUMO

En este estudio fueron evaluados prospectivamente los efectos de un compuesto Antiácido/Acido Algínico (Batynid R) mediante técnicas radiosotópicas. Los pacientes fueron divididos en 2 grupos: esofagitis moderada, 13 pacientes y esofagitis serias, 13 pacientes. El estudio isotópico fue realizado antes y posterior a la ingesta del compuesto evaluando la duración, severidad y n§ de episodios de reflujo. Los resultados no mostraron diferencias significativas comparando el reflujo gástrico antes y después del BATYNID R, en ambos grupos de pacientes, considerando todos los pacientes estudiados


Assuntos
Humanos , Alginatos/uso terapêutico , Antiácidos/uso terapêutico , Refluxo Gastroesofágico/prevenção & controle , Esofagite/complicações , Estudos Prospectivos , Refluxo Gastroesofágico
4.
Rev. Asoc. Odontol. Argent ; 78(4): 234-8, 1990 Oct-Dec.
Artigo em Espanhol | LILACS-Express | LILACS, BINACIS | ID: biblio-1170169

RESUMO

Reconstruction of the mandible with iliac crest bone graft has been reported since early 1900’S. The series go from one to 160 cases published. This article shows the way we approached de reconstruction of a patient who came with an hemimandibulectomy due to osteosarcoma.

5.
Santiago; CECIDEP; ene. 1988. 274 p. ilus.
Monografia em Espanhol | LILACS | ID: lil-152693
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA